N-[(pyrimidinylamino)propanyl]-and N[(pyrazinylamino)proppanyl]arylcarboxamides

The present invention relates to novel N-[(Pyrimidinylamino)propanyl]- and N-[(Pyrazinylamino)-propanyl]arylcarboxamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having...

Full description

Saved in:
Bibliographic Details
Main Authors Scheuerer Stefan, Heine Niklas, Ferrara Marco, Lessel Uta Friederike, Nicholson Janet Rachel, Pekcec Anton, Riether Doris
Format Patent
LanguageEnglish
Published 06.02.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to novel N-[(Pyrimidinylamino)propanyl]- and N-[(Pyrazinylamino)-propanyl]arylcarboxamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having an association with the orexin sub-type 1 receptor.
Bibliography:Application Number: US201715485262